Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


16.10.2017

1 Am J Hematol
2 Biochem Biophys Res Commun
2 Blood
4 Br J Haematol
1 Cancer Res
2 Cell
1 Clin Infect Dis
1 Hematol Oncol Clin North Am
1 J Immunol
4 J Pediatr Hematol Oncol
1 Leuk Lymphoma
4 Leuk Res
4 Leukemia
5 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. PATNAIK MM, Vallapureddy R, Yalniz FF, Hanson CA, et al
    Therapy Related-Chronic Myelomonocytic Leukemia (CMML): Molecular, Cytogenetic and Clinical Distinctions from de novo CMML.
    Am J Hematol. 2017 Oct 11. doi: 10.1002/ajh.24939.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. LIN N, Fu W, Zhao C, Li B, et al
    Biologico-clinical significance of DNMT3A variants expression in acute myeloid leukemia.
    Biochem Biophys Res Commun. 2017 Oct 9. pii: S0006-291X(17)32011.
    PubMed     Text format     Abstract available

  3. JIANG MJ, Dai JJ, Gu DN, Huang Q, et al
    MicroRNA-7 inhibits cell proliferation of chronic myeloid leukemia and sensitizes it to imatinib in vitro.
    Biochem Biophys Res Commun. 2017 Oct 3. pii: S0006-291X(17)31963.
    PubMed     Text format     Abstract available


    Blood

  4. APPELBAUM FR, Bernstein ID
    Gemtuzumab ozogamicin for acute myeloid leukemia.
    Blood. 2017 Oct 11. pii: blood-2017-09-797712. doi: 10.1182/blood-2017-09-797712
    PubMed     Text format     Abstract available

  5. MAR BG, Chu SH, Kahn JD, Krivstov AV, et al
    SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia.
    Blood. 2017 Oct 10. pii: blood-2017-03-775569. doi: 10.1182/blood-2017-03-775569
    PubMed     Text format     Abstract available


    Br J Haematol

  6. GHAMLOUCH H, Nguyen-Khac F, Bernard OA
    Chronic lymphocytic leukaemia genomics and the precision medicine era.
    Br J Haematol. 2017;178:852-870.
    PubMed     Text format     Abstract available

  7. GOCKERITZ E, Vondey V, Guastafierro A, Pizevska M, et al
    Establishing a chemical genetic link between Bruton tyrosine kinase activity in malignant B cells and cell functions involved in the micro-environmental dialogue.
    Br J Haematol. 2017;178:949-953.
    PubMed     Text format     Abstract available

  8. FENAUX P, Muus P, Kantarjian H, Lyons RM, et al
    Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy.
    Br J Haematol. 2017;178:906-913.
    PubMed     Text format     Abstract available

  9. HAN LJ, Wang Y, Fan ZP, Huang F, et al
    Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remission.
    Br J Haematol. 2017;179:120-130.
    PubMed     Text format     Abstract available


    Cancer Res

  10. SABA NS, Wong DH, Tanios G, Iyer JR, et al
    MALT1 inhibition is efficacious in both naive and ibrutinib-resistant chronic lymphocytic leukemia.
    Cancer Res. 2017 Oct 9. pii: canres.2485.2017.
    PubMed     Text format     Abstract available


    Cell

  11. ISODA T, Moore AJ, He Z, Chandra V, et al
    Non-coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate.
    Cell. 2017;171:103-119.
    PubMed     Text format     Abstract available

  12. CHEN Z, Chen SJ
    Poisoning the Devil.
    Cell. 2017;168:556-560.
    PubMed     Text format    


    Clin Infect Dis

  13. WOLF J, Tang L, Flynn PM, Pui CH, et al
    Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
    Clin Infect Dis. 2017 Sep 14. doi: 10.1093.
    PubMed     Text format     Abstract available


    Hematol Oncol Clin North Am

  14. GHIAUR G, Levis M
    Mechanisms of Resistance to FLT3 Inhibitors and the Role of the Bone Marrow Microenvironment.
    Hematol Oncol Clin North Am. 2017;31:681-692.
    PubMed     Text format     Abstract available


    J Immunol

  15. KIM YH, Kumar A, Chang CH, Pyaram K, et al
    Reactive Oxygen Species Regulate the Inflammatory Function of NKT Cells through Promyelocytic Leukemia Zinc Finger.
    J Immunol. 2017 Oct 11. pii: ji1700567. doi: 10.4049/jimmunol.1700567.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  16. ERKER C, Huppler AR, Walsh TJ, McCormick ME, et al
    Successful Treatment of Invasive Conidiobolus Infection During Therapy for Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Oct 5. doi: 10.1097/MPH.0000000000000985.
    PubMed     Text format     Abstract available

  17. ESTEPP JH, Smeltzer MP, Kang G, Howard SC, et al
    Safe Use of Low-Molecular-weight Heparin in Pediatric Acute Lymphoblastic Leukemia and Lymphoma Around Lumbar Punctures.
    J Pediatr Hematol Oncol. 2017 Oct 4. doi: 10.1097/MPH.0000000000000988.
    PubMed     Text format     Abstract available

  18. CHENG G, Ozgonenel B, Bhambhani K, Kapur G, et al
    Recurrent Atypical Hemolytic Uremic Syndrome in Children With Acute Lymphoblastic Leukemia Undergoing Maintenance Chemotherapy.
    J Pediatr Hematol Oncol. 2017 Oct 4. doi: 10.1097/MPH.0000000000000987.
    PubMed     Text format     Abstract available

  19. VATSAYAN A, Talati R, Nagle K, Cabral L, et al
    Complete Resolution of Lymphoid Interstitial Pneumonia in a Patient With Juvenile Myelomonocytic Leukemia Treated With Allogeneic Bone Marrow Transplant: Killing 2 Birds With 1 Stone.
    J Pediatr Hematol Oncol. 2017 Oct 11. doi: 10.1097/MPH.0000000000000977.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  20. ZHANG C, Amos Burke GA
    Pediatric precursor B-cell acute lymphoblastic leukemia with MYC 8q24 translocation - how to treat?
    Leuk Lymphoma. 2017 Oct 12:1-7. doi: 10.1080/10428194.2017.1387914.
    PubMed     Text format     Abstract available


    Leuk Res

  21. CHEN CY, Chang PC, Wang TH, Wang TV, et al
    The in vivo anti-leukemia activity of N-(1-Pyrenlyl) maleimide in a bioluminescent mouse model.
    Leuk Res. 2017;62:64-69.
    PubMed     Text format     Abstract available

  22. BOUVY C, Wannez A, Laloy J, Chatelain C, et al
    Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo.
    Leuk Res. 2017;62:70-76.
    PubMed     Text format     Abstract available

  23. VISANI G, Ferrara F, Di Raimondo F, Loscocco F, et al
    Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study.
    Leuk Res. 2017;62:77-83.
    PubMed     Text format     Abstract available

  24. HORSTER L, Schlenk RF, Stadler M, Gabriel M, et al
    Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype.
    Leuk Res. 2017;62:84-90.
    PubMed     Text format     Abstract available


    Leukemia

  25. VALENT P, Sotlar K, Blatt K, Hartmann K, et al
    Proposed diagnostic criteria and classification of basophilic leukemias and related disorders.
    Leukemia. 2017;31:788-797.
    PubMed     Text format     Abstract available

  26. HEATH EM, Chan SM, Minden MD, Murphy T, et al
    Biological and clinical consequences of NPM1 mutations in AML.
    Leukemia. 2017;31:798-807.
    PubMed     Text format     Abstract available

  27. TOPP MS, Stelljes M, Zugmaier G, Barnette P, et al
    Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia.
    Leukemia. 2017 Oct 9. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  28. YAN F, Shen N, Pang JX, Zhao N, et al
    A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target.
    Leukemia. 2017 Oct 10. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    PLoS One

  29. CHOI SH, Severson E, Pear WS, Liu XS, et al
    The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia.
    PLoS One. 2017;12:e0185762.
    PubMed     Text format     Abstract available

  30. WONG SM, Liu FH, Lee YL, Huang HM, et al
    Correction: MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.
    PLoS One. 2017;12:e0186531.
    PubMed     Text format     Abstract available

  31. LEE YL, Chen CW, Liu FH, Huang YW, et al
    Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation.
    PLoS One. 2017;12:e0186528.
    PubMed     Text format     Abstract available

  32. BUTI M, Manzano ML, Morillas RM, Garcia-Retortillo M, et al
    Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
    PLoS One. 2017;12:e0184550.
    PubMed     Text format     Abstract available

  33. WEIR MC, Hellwig S, Tan L, Liu Y, et al
    Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth.
    PLoS One. 2017;12:e0181178.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: